Lupus Nephritis
- All
- News
'Lupus Nephritis' - 1 News Result(s)
-
Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval
Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C
'Lupus Nephritis' - 1 News Result(s)
-
Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval
Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C
